Approval · Notice of Compliance 7982 · 2006
REVATIO: Notice of Compliance 7982
Issued May 26, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7982
- Date
- May 26, 2006
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- CGMP Specific Phosphodiesterase Type 5 Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REVATIO | 02279401 | Marketed |
Medicinal ingredients
- SILDENAFIL CITRATE 20 MG per TAB